loadpatents
name:-0.019130945205688
name:-0.005424976348877
name:-0.0071167945861816
ANAVI-GOFFER; Sharon Patent Filings

ANAVI-GOFFER; Sharon

Patent Applications and Registrations

Patent applications and USPTO patent grants for ANAVI-GOFFER; Sharon.The latest application filed is for "treatment of schizophrenia using beta-caryophyllene and cb2 receptor agonists".

Company Profile
11.5.19
  • ANAVI-GOFFER; Sharon - Oranit IL
  • Anavi-Goffer; Sharon - Aberdeen GB
  • Anavi-Goffer; Sharon - Ashdod IL
  • Anavi-Goffer; Sharon - Ashod IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Treatment Of Schizophrenia Using Beta-caryophyllene And Cb2 Receptor Agonists
App 20200261374 - ANAVI-GOFFER; Sharon ;   et al.
2020-08-20
Treatment Of Mental, Movement And Behavioral Disorders
App 20190321355 - Anavi-Goffer; Sharon
2019-10-24
Genetic Susceptibility Diagnosis And Treatment Of Mental Disorders
App 20190241962 - Anavi-Goffer; Sharon
2019-08-08
Compositions Of Cb2 Receptor Selective Agonists For Treatment Of Mental Disorders
App 20190070124 - Anavi-Goffer; Sharon
2019-03-07
Self-Emulsifying Compositions of CB2 Receptor Modulators
App 20190060300 - Anavi-Goffer; Sharon
2019-02-28
Program Randomization For Cyber-attack Resilient Control In Programmable Logic Controllers
App 20190008845 - Canedo; Arquimedes Martinez
2019-01-10
CB2 receptor ligands for the treatment of psychiatric disorders
Grant 10,016,373 - Anavi-Goffer , et al. July 10, 2
2018-07-10
Phytocannabinoids In The Treatment Of Cancer
App 20180042975 - Parolaro; Daniela ;   et al.
2018-02-15
Phytocannabinoids in the treatment of cancer
Grant 9,675,654 - Parolaro , et al. June 13, 2
2017-06-13
Treatment Of Schizophrenia Using Beta-caryophyllene And Cb2 Receptor Agonists
App 20170151182 - Anavi-Goffer; Sharon ;   et al.
2017-06-01
Cb2 Receptor Ligands For The Treatment Of Psychiatric Disorders
App 20170042832 - Anavi-Goffer; Sharon ;   et al.
2017-02-16
Cb2 Receptor Ligands For The Treatment Of Psychiatric Disorders
App 20160089349 - ANAVI-GOFFER; Sharon ;   et al.
2016-03-31
Phytocannabinoids In The Treatment Of Cancer
App 20150086653 - Parolaro; Daniela ;   et al.
2015-03-26
Treatment Of Schizophrenia Using Beta-caryophyllene And Cb2 Receptor Agonists
App 20150051299 - Anavi-Goffer; Sharon ;   et al.
2015-02-19
Phytocannabinoids in the treatment of cancer
Grant 8,790,719 - Parolaro , et al. July 29, 2
2014-07-29
Phytocannabinoids In The Treatment Of Cancer
App 20130059018 - Parolaro; Daniela ;   et al.
2013-03-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed